Moderna soars 8% premarket on cancer vaccine results



Moderna shares jumped more than 8% in Tuesday’s premarket session on news that a study of Moderna and Merck’s mRNA-based cancer vaccine showed promising results.

The two firms said the combin…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento